Potassium Carbonate → HCID 11199618, compound
Reaction equation
[N:1]1([C:8]2[CH:9]=[CH:10][C:11]3[N:12]([C:14]([C:17]4[N:22]=[C:21](O)[CH:20]=[CH:19][CH:18]=4)=[N:15][N:16]=3)[N:13]=2)[CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.P(Br)(Br)[Br:25].C(=O)([O-])[O-].[K+].[K+]>>[N:1]1([C:8]2[CH:9]=[CH:10][C:11]3[N:12]([C:14]([C:17]4[CH:18]=[CH:19][CH:20]=[C:21]([Br:25])[N:22]=4)=[N:15][N:16]=3)[N:13]=2)[CH2:7][CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1Participants
Conditions
- Temperature
- 130 °C
Procedure
A mixture of 6-(6-azepan-1-yl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)pyridine-2-ol (700 mg) and phosphorus tribromide (7 ml) was stirred at 130° C. for 6 hours. After allowing to cool to room temperature, an ice-water was added, and the mixture was neutralized with saturated aqueous solution of potassium carbonate, and extracted with chloroform. The extract was washed with saturated aqueous solution of sodium hydrogen carbonate and brine, dried over anhydrous sodium sulfate, and then concentrated under reduced pressure. The resultant residue was purified by silica gel column chromatography (eluent: chloroform:methanol=98:2) and recrystallized from ethanol to obtain 6-azepan-1-yl-3-(6-bromopyridin-2-yl)-1,2,4-triazolo[4,3-b]pyridazine (240 mg) as colorless crystals.
Workup
- temperatureto cool to room temperature
- extractionextracted with chloroform
- washThe extract was washed with saturated aqueous solution of sodium hydrogen carbonate and brine
- dry with materialdried over anhydrous sodium sulfate
- concentrationconcentrated under reduced pressure
- customThe resultant residue was purified by silica gel column chromatography (eluent: chloroform:methanol=98:2)
- customrecrystallized from ethanol
Sources & evidence
- ORD record
- ord-eae19cea7f3d4f7b8a127e980f2f2c04
- Source dataset
- uspto-grants-2007_02
- Patent number
- US07173033B2
Reaction notes
Loading…